List of works - Petra Steinacker

A multi-center study of neurofilament assay reliability and inter-laboratory variability

scientific article published on 19 June 2020

Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

scientific article

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

scientific article published on 07 August 2006

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

scientific article published in August 2003

Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease

scientific article published on 30 December 2020

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression

scientific article published on 15 November 2017

Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion

scientific article published on 04 March 2020

Different CSF β-amyloid processing in Alzheimer’s and Creutzfeldt–Jakob disease

scientific article published on 06 January 2011

Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase

scientific article published on 17 September 2018

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment

scientific article published on 01 January 2019

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.

scientific article

Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data

scientific article

Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias

scientific article published on 08 February 2017

Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia

scientific article published on 24 March 2019

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

scientific article published on 11 October 2018

Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD.

scientific article

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies

scientific article

Serum neurofilament light chain in behavioral variant frontotemporal dementia

scientific article published on 12 September 2018

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies

scientific article published on 5 January 2005

Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies.

scientific article published in January 2006

List of works by Petra Steinacker

A multi-center study of neurofilament assay reliability and inter-laboratory variability

Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression

Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion

Different CSF β-amyloid processing in Alzheimer’s and Creutzfeldt–Jakob disease

Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.

Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data

Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias

Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD.

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies

Serum neurofilament light chain in behavioral variant frontotemporal dementia

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies

Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies.